Related Experiment Video
Updated: Jan 7, 2026

06:08
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
1.0K
Multiple primary cancers with prostate malignant tumor as the initial diagnosis: a case report
1Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, Zhejiang, People's Republic Of China.
Discover Oncology
|December 11, 2025
Summary
This case study details a rare instance of multiple primary cancers (MPC) in an elderly male, involving four distinct tumors. Aggressive surgical management and genetic testing, including EGFR and BAP1 mutations, improved his quality of life.
Area of Science:
- Oncology
- Genetics
- Urology
Background:
- Cancer patient survival is increasing due to medical advancements.
- Multiple primary cancers (MPC) are a growing concern with poorer prognoses.
- Current management guidelines for MPC are lacking.
Purpose of the Study:
- To report a rare case of an elderly male with four distinct primary cancers.
- To highlight the coexistence of EGFR mutation and BAP1 deletion in different tumors.
- To emphasize the importance of genetic testing and aggressive management in MPC.
Main Methods:
- Longitudinal case study over a six-year follow-up period.
- Surgical interventions for each primary tumor: radical prostatectomy, partial nephrectomy, transurethral resection of bladder tumor, and radical lung resection.
- Genetic testing of tumor tissues for mutations (EGFR) and deletions (BAP1).
Main Results:
- Diagnosis of four primary cancers: prostate, renal, bladder, and lung cancer.
- Identification of an EGFR mutation in lung cancer and BAP1 gene deletion in renal cancer.
- Successful surgical treatment and good postoperative recovery for all primary tumors.
Conclusions:
- This case represents a rare instance of MPC involving three urogenital system tumors.
- The coexistence of EGFR and BAP1 alterations across different cancers is noteworthy.
- Aggressive management and genetic profiling are crucial for improving quality of life in MPC patients.

